Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

0.9199

-0.0002 (-0.02%)

At close: Apr 24, 2026, 4:00 PM EDT

0.9000

-0.0199 (-2.16%)

After-hours: Apr 24, 2026, 4:00 PM EDT

ZYBT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	44	-	-	-	-
Market Cap Growth	-74.73%	-	-	-	-
Enterprise Value	48.92	0	0	0	0
Debt / Equity Ratio	0.23	0.22	0.26	0.18	0.09
Debt / EBITDA Ratio	-38.75	2.13	1.30	0.77	0.44
Debt / FCF Ratio	280.27	3.15	2.20	-6.49	2.35
Net Debt / Equity Ratio	0.13	0.23	0.27	0.19	0.09
Net Debt / EBITDA Ratio	-17.23	1.64	1.07	0.65	0.35
Net Debt / FCF Ratio	124.62	2.42	1.80	-5.52	1.86
Asset Turnover	0.31	0.38	0.42	0.54	0.48
Inventory Turnover	1.72	1.63	1.66	2.27	2.03
Quick Ratio	0.81	0.78	0.77	0.95	0.86
Current Ratio	1.49	1.31	1.26	1.41	1.31
Return on Equity (ROE)	-6.36%	3.89%	10.78%	16.50%	14.57%
Return on Assets (ROA)	-4.50%	3.10%	7.56%	11.90%	10.30%
Return on Invested Capital (ROIC)	-5.38%	3.58%	8.94%	14.62%	12.81%
Return on Capital Employed (ROCE)	-7.52%	4.65%	12.55%	19.16%	16.39%
Payout Ratio	-	141.66%	125.42%	45.84%	28.36%
Buyback Yield / Dilution	-1.81%	0.00%	0.00%	0.00%	-
Total Shareholder Return	-1.81%	0.00%	0.00%	0.00%	-

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q